Precision Medicine

Ginkgo and Aura Genetics Revolutionize At-Home Diagnostic Testing
Tech & Innovation Ginkgo and Aura Genetics Revolutionize At-Home Diagnostic Testing

At-home diagnostic testing is entering a new era thanks to the collaboration between Ginkgo Automation and Aura Genetics. Together, they aim to accelerate innovation in the healthcare and wellness markets by leveraging advanced laboratory automation and technologies to streamline and scale

Harnessing Tumor Organoids for Advanced Cancer Research
Biotech & Bioprocessing Harnessing Tumor Organoids for Advanced Cancer Research

In the quest to understand and treat cancer, researchers have faced significant obstacles with traditional models such as two-dimensional cell cultures and in vivo xenografts. These methods, while useful in their own right, often fall short in accurately replicating the complex architecture and

Revolutionizing Surgery: DIP Technology in 3D Bioprinting
Biotech & Bioprocessing Revolutionizing Surgery: DIP Technology in 3D Bioprinting

3D printing technology is paving the way for significant advancements in the medical field, particularly within plastic and reconstructive surgery. The introduction of dynamic interface printing (DIP) promises to transform tissue engineering, making it possible to create patient-specific,

Can Blood Pressure Control Lower Dementia Risk?
Tech & Innovation Can Blood Pressure Control Lower Dementia Risk?

The link between blood pressure management and the reduction of dementia risk has been the subject of recent scientific inquiry. With the aging global population, dementia has become a significant public health concern, particularly in communities with high rates of hypertension. A recent study by

Pharmacogenomics: Enhancing Safety in Cancer Treatment
Research & Development Pharmacogenomics: Enhancing Safety in Cancer Treatment

In the dynamic world of modern medicine, expectations run high for treatments that are not only effective but also minimize risks. Yet, conventional cancer therapies often walk a fine line between disease eradication and severe side effects. What if there was a way to tailor treatments to each

Can Glycomine's $115M Funded Drug Transform Rare Disease Treatment?
Tech & Innovation Can Glycomine's $115M Funded Drug Transform Rare Disease Treatment?

Glycomine, a leading biotechnology company based in San Francisco, has achieved a notable milestone by raising $115 million in funding for their pioneering project, GLM101. This development is particularly significant in an economic environment where securing substantial capital remains

Loading

Subscribe to our weekly news digest.

Join now and become a part of our fast-growing community.

Invalid Email Address
Thanks for Subscribing!
We'll be sending you our best soon!
Something went wrong, please try again later